N. Després

1.2k total citations
10 papers, 956 citations indexed

About

N. Després is a scholar working on Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, N. Després has authored 10 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Infectious Diseases. Recurrent topics in N. Després's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Heart Failure Treatment and Management (3 papers) and Cardiac pacing and defibrillation studies (2 papers). N. Després is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Heart Failure Treatment and Management (3 papers) and Cardiac pacing and defibrillation studies (2 papers). N. Després collaborates with scholars based in Canada, United States and Netherlands. N. Després's co-authors include Andrew Grant, Elvy Lapointe, Tatsuo Senshu, Annemarie van der Heijden, Walther J. van Venrooij, Henri A. Ménard, Erik R Vossenaar, Gilles Boire, Barry Bluestein and Alan H.B. Wu and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Chemistry and Clinica Chimica Acta.

In The Last Decade

N. Després

10 papers receiving 916 citations

Peers

N. Després
H. Wurm Austria
Mary H. Foster United States
Birgit Kovacs United States
Clio Ribbens Belgium
Alice C. Allen United Kingdom
H. Wurm Austria
N. Després
Citations per year, relative to N. Després N. Després (= 1×) peers H. Wurm

Countries citing papers authored by N. Després

Since Specialization
Citations

This map shows the geographic impact of N. Després's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Després with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Després more than expected).

Fields of papers citing papers by N. Després

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Després. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Després. The network helps show where N. Després may publish in the future.

Co-authorship network of co-authors of N. Després

This figure shows the co-authorship network connecting the top 25 collaborators of N. Després. A scholar is included among the top collaborators of N. Després based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Després. N. Després is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Belenky, Alexander, Andrew M. Smith, Bin Zhang, et al.. (2004). The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. Clinica Chimica Acta. 340(1-2). 163–172. 62 indexed citations
2.
Vossenaar, Erik R, N. Després, Elvy Lapointe, et al.. (2004). Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Research & Therapy. 6(2). R142–50. 383 indexed citations
3.
Wians, Frank H., Andrew Grant, Jonathan Bailey, et al.. (2004). Evaluation of the analytical performance characteristics of the Bayer ACS:180® B-type natriuretic peptide (BNP) assay. Clinica Chimica Acta. 353(1-2). 147–155. 4 indexed citations
4.
Wu, Alan H.B., Milton Packer, Andrew M. Smith, et al.. (2004). Analytical and Clinical Evaluation of the Bayer ADVIA Centaur Automated B-Type Natriuretic Peptide Assay in Patients with Heart Failure: A Multisite Study. Clinical Chemistry. 50(5). 867–873. 116 indexed citations
5.
Martel, Jan, N. Després, Charaf E Ahnadi, et al.. (2000). Comparative Multicentre Study of a Panel of Thyroid Tests Using Different Automated Immunoassay Platforms and Specimens at High Risk of Antibody Interference. Clinical Chemistry and Laboratory Medicine (CCLM). 38(8). 785–793. 21 indexed citations
6.
Després, N. & Andrew Grant. (1998). Antibody interference in thyroid assays: a potential for clinical misinformation. Clinical Chemistry. 44(3). 440–454. 174 indexed citations
7.
Després, N., et al.. (1997). Evaluation of the valproic acid assay on the bayer technicon immuno 1″ system. Clinical Biochemistry. 30(4). 372–372. 1 indexed citations
8.
Després, N., Guylaine Talbot, Bianca Plouffe, Gilles Boire, & H A Ménard. (1995). Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.. Journal of Clinical Investigation. 95(4). 1891–1896. 47 indexed citations
9.
Després, N., et al.. (1994). The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.. PubMed. 21(6). 1027–33. 147 indexed citations
10.
Després, N., et al.. (1991). Immunopathological and Immunochemical Analysis of Autoimmune Enterocolitis in Mice. Digestion. 49(2). 106–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026